Skip to main content

Difficult-to-Treat Hyperthyroidism

  • Chapter
Endocrinology and Diabetes

Abstract

This case illustrates a 31-year-old female who presented with thyrotoxicosis and mild thyroid eye disease. Questions relating to this common thyroid condition are addressed in a systematic fashion, including a summary of the clinical signs and symptoms, the appropriate biochemical and radiological investigations, management and follow-up. This case nicely demonstrates the spectrum and heterogeneity of hyperthyroidism in terms of disease severity and response to medication. Although most patients respond well to anti-thyroid drugs, this patient was refractory to this treatment, as shown by her growing goitre and worsening biochemical results despite high dosages of carbimazole. Her condition was eventually treated with total thyroidectomy. The management options for more aggressive Graves’ disease are discussed along with other questions about the case study.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 119.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Mier A, Brophy C, Wass JA, Besser GM, Green M. Reversible respiratory muscle weakness in hyperthyroidism. Am Rev Respir Dis. 1989;139(2):529–33.

    Article  CAS  PubMed  Google Scholar 

  2. Kendall-Taylor P, Perros P. Clinical presentation of thyroid associated orbitopathy. Thyroid. 1998;8(5):427–8.

    Article  CAS  PubMed  Google Scholar 

  3. Bartalena L, Marcocci C, Tanda ML, Manetti L, Dell’Unto E, Bartolomei MP, et al. Cigarette smoking and treatment outcome in Graves’ ophthalmopathy. Ann Intern Med. 1998;129:633–5.

    Article  Google Scholar 

  4. Vestergaard P. Smoking and thyroid disorders – a meta-analysis. Eur J Endocrinol. 2002;146(2):153–61.

    Article  CAS  PubMed  Google Scholar 

  5. Strieder TG, Tijssen JG, Wenzel BE, Endert E, Wiersinga WM. Prediction of progression to overt hypothyroidism or hyperthyroidism in female relatives of patients with autoimmune thyroid disease using the Thyroid Events Amsterdam (THEA) score. Arch Intern Med. 2008;168(15):1657–63.

    Article  PubMed  Google Scholar 

  6. Weetman AP, Tomlinson K, Amos N, Lazarus JH, Hall R, McGregor AM. Proteinuria in autoimmune thyroid disease. Acta Endocrinol (Copenh). 1985;109(3):341–7.

    CAS  Google Scholar 

  7. Androuny A, Sandler RM, Carmel R. Variable presentation of thrombocytopenia in Graves’ disease. Arch Intern Med. 1982;142(8):1460–4.

    Article  Google Scholar 

  8. Mitchell AL, Pearce SH. How should we treat patients with low serum thyrotropin concentrations? Clin Endocrinol. 2010;72(3):292–6.

    Article  CAS  Google Scholar 

  9. Yoshimura Noh J, Momotani N, Fukada S, Ito K, Miyauchi A, Amino N. Ratio of serum free triiodothyronine to free thyroxine in Graves’ hyperthyroidism and thyrotoxicosis caused by painless thyroiditis. Endocr J. 2005;52(5):537–42.

    Article  CAS  PubMed  Google Scholar 

  10. Eckstein AK, Plicht M, Lax H, Neuhauser M, Mann K, Lederbogen S, et al. Thyrotropin receptor autoantibodies are independent risk factors for Graves’ ophthalmopathy and help to predict severity and outcome of the disease. J Cin Endocrinol Metab. 2006;91(9):3464–70.

    Article  CAS  Google Scholar 

  11. Grebe SK, Feel CM, Ford HC, Fagerstrom JN, Cordwell DP, Delahunt JW, et al. A randomized trial of short-term treatment of Graves’ disease with high-dose carbimazole plus thyroxine versus low-dose carbimazole. Clin Endocrinol (Oxf). 1998;48(5):585–92.

    Article  CAS  Google Scholar 

  12. Bartalena L, Marcocci C, Bogazzi F, Manetti L, Tanda ML, Dell’Untol E, et al. Relation between therapy for hyperthyroidism and the course of Graves’ ophthalmopathy. N Engl J Med. 1998;338(2):73–8.

    Article  CAS  PubMed  Google Scholar 

  13. Lai A, Sassi L, Compri E, Marino F, Sivelli P, Piantanida E, et al. Lower dose prednisolone prevents radioiodine-associated exacerbation of initially mild or absent graves’ orbitopathy: a retrospective cohort study. J Clin Endocrinol Metab. 2010;95(3):1333–7.

    Article  CAS  PubMed  Google Scholar 

Suggested Reading

  • Braverman LE, Cooper D. Werner & Ingbar’s the thyroid: a fundamental and clinical text. 10th ed. Philadelphia: Lippincott, Williams & Wilkins; 2012.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Earn H. Gan MBChB, MRCP .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag London

About this chapter

Cite this chapter

Gan, E.H., Pearce, S.H.S. (2015). Difficult-to-Treat Hyperthyroidism. In: Ajjan, R., Orme, S. (eds) Endocrinology and Diabetes. Springer, London. https://doi.org/10.1007/978-1-4471-2789-5_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-2789-5_1

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-2788-8

  • Online ISBN: 978-1-4471-2789-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics